Breaking News Instant updates and real-time market news.

CARA

Cara Therapeutics

$13.30

0.01 (0.08%)

16:26
08/03/17
08/03
16:26
08/03/17
16:26

Cara Therapeutics reports Q2 EPS (29c), consensus (62c)

"During the quarter, we continued to make good progress with our CR845 development programs in acute postoperative pain, chronic osteoarthritis pain and chronic kidney disease-associated pruritus. Importantly, we were very pleased to receive Breakthrough Therapy designation from the FDA for I.V. CR845 for the treatment of CKD-aP in hemodialysis patients, and expect to meet with the FDA in the third quarter of 2017 to finalize our pivotal program for this indication. We look forward to expanding our development activities in pruritus with Oral CR845 later this year through the initiation of a Phase 1 study in non-dialysis CKD patients and the submission of an IND application for the treatment of chronic liver disease-associated pruritus," said CEO Derek Chalmers.

  • 03

    Aug

CARA Cara Therapeutics
$13.30

0.01 (0.08%)

06/30/17
06/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Celgene (CELG) downgraded to Neutral from Buy at BTIG with analyst Dane Leone citing a reduction in Mongersen and Ozanimod estimates. 2. Cara Therapeutics (CARA) downgraded to Neutral from Buy at Janney Capital with analyst Ken Trbovich saying the results of Cara Therapeutics' first placebo-controlled study of oral CR845 do not mean the end to development of the agent for chronic pain, but they also do not allow Cara to advance to a pivotal study next year, as he believes investors were expecting. 3. AmerisourceBergen (ABC) downgraded to Neutral from Buy at BofA/Merrill with analyst Steven Valiquette saying AmerisourceBergen is up 20% year-to-date but believes further upside will be difficult as data indicates generic pricing deflation accelerated in May. 4. RE/MAX Holdings (RMAX) downgraded to Underperform from Neutral at BofA/Merrill. 5. Vipshop (VIPS) downgraded to Hold from Buy at Deutsche Bank with analyst Alan Hellawell saying he has "competitive pressure and growth concerns" with June seeing industry-wide discounting. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/30/17
JANY
06/30/17
DOWNGRADE
Target $21
JANY
Neutral
Cara Therapeutics downgraded to Neutral from Buy at Janney Capital
Janney Capital analyst Ken Trbovich said the results of Cara Therapeutics' first placebo-controlled study of oral CR845 do not mean the end to development of the agent for chronic pain, but they also do not allow Cara to advance to a pivotal study next year, as he believes investors were expecting. Given that the pivotal study for this program has been pushed out to 2019/2020 from 2018 and that these results, combined with the decision a week ago to increase enrollment in the ongoing adaptive Phase 3 study of I.V. CR845 in postsurgical pain, gives him less confidence in a positive outcome for the Phase 3 than he'd previously had, Trbovich downgraded Cara to Neutral from Buy and lowered his fair value estimate to $21 from $22.
06/30/17
HCWC
06/30/17
NO CHANGE
Target $30
HCWC
Buy
Cara study results 'could have been far worse,' says H.C. Wainwright
H.C. Wainwright analyst Corey Davis says that even though Cara Therapeutics missed the primary endpoint in its Phase 2 study with oral CR845 in osteoarthritis pain, the company "unequivocally showed" a positive signal in the pre-specified subset of patients with hip osteoarthritis, but not knee. Most importantly, CR845 showed an "incredibly benign side effect profile," Davis tells investors in a research note. The analyst calls CR845 the first ever successful proof of concept study for an oral kappa opioid with virtually no side effects. The study "could have been far worse," and while not an obvious win that allows progression to Phase 3, the next step will be to conduct another Phase 2 with changes that can optimize the chances of CR845 showing clear efficacy. Davis keeps a Buy rating on Cara shares with a $30 price target. The stock in premarket trading is down 29%, or $7.52, to $17.99.
06/30/17
PIPR
06/30/17
NO CHANGE
Target $27
PIPR
Overweight
Cara Therapeutics selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Charles Duncan believes last night's Phase II trial results from Cara Therapeutics with oral CR845 in osteoarthritis hip and knee pain are "encouraging" at the highest 5mg dose. These results suggest oral CR845 has analgesic efficacy, with a differentiated safety/tolerability profile for a chronic agent, Duncan tells investors in a research note. He recommends using any stock weakness as a buying opportunity and keeps an Overweight rating on Cara with a $27 price target.

TODAY'S FREE FLY STORIES

SM

SM Energy

$13.47

-0.0792 (-0.58%)

11:00
08/22/17
08/22
11:00
08/22/17
11:00
Options
Opening buyer snaps up SM Energy downside 12.5 puts »

Opening buyer snaps up SM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

YPF

YPF

$20.14

0.28 (1.41%)

10:55
08/22/17
08/22
10:55
08/22/17
10:55
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$30.54

-0.29 (-0.94%)

10:52
08/22/17
08/22
10:52
08/22/17
10:52
Conference/Events
Columbus McKinnon management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

  • 29

    Nov

  • 30

    Nov

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

, BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

10:44
08/22/17
08/22
10:44
08/22/17
10:44
Hot Stocks
S&P removes Berkshire Hathaway from CreditWatch, calls outlook 'stable' »

S&P Global Ratings…

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$23.78

0.4 (1.71%)

10:40
08/22/17
08/22
10:40
08/22/17
10:40
Options
Bank of America calls active as shares see strength »

Bank of America calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
08/22/17
08/22
10:40
08/22/17
10:40
General news
Treasury Option Action: a build-up of bullish call butterflies »

Treasury Option Action: a…

WILC

G. Willi-Food

$6.49

-0.0209 (-0.32%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Hot Stocks
G. Willi-Food names Zwi Williger as co-chairman »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$8.37

-0.18 (-2.11%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/22/17
08/22
10:35
08/22/17
10:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Recommendations
Medtronic, Dexcom, TNDM analyst commentary  »

Medtronic challenges in…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

TWX

Time Warner

$101.67

-0.44 (-0.43%)

, T

AT&T

$37.63

0.045 (0.12%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Periodicals
Time Warner-AT&T deal questioned by Brazil regulator, Bloomberg says »

Brazils antitrust…

TWX

Time Warner

$101.67

-0.44 (-0.43%)

T

AT&T

$37.63

0.045 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FCX

Freeport McMoRan

$15.37

0.6399 (4.34%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Technical Analysis
Technical View: Freeport McMoRan breaks through top of recent range »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$18.92

3.23 (20.59%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Downgrade
DSW rating change  »

DSW downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RDFN

Redfin

$27.56

0.86 (3.22%)

, EGN

Energen

$50.21

0.65 (1.31%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on the…click here.

RDFN

Redfin

$27.56

0.86 (3.22%)

EGN

Energen

$50.21

0.65 (1.31%)

PXD

Pioneer Natural

$128.63

0.69 (0.54%)

RVNC

Revance

$22.70

-0.45 (-1.94%)

PCRX

Pacira

$35.75

-0.05 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

  • 25

    Sep

  • 02

    Nov

MYL

Mylan

$30.44

-0.28 (-0.91%)

, BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MYL

Mylan

$30.44

-0.28 (-0.91%)

BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

GMRE

Global Medical REIT

$8.38

-0.6 (-6.68%)

NXTM

NxStage Medical

$29.11

-0.14 (-0.48%)

FMS

Fresenius Medical

$46.69

0.37 (0.80%)

HKMPY

Hikma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 03

    Sep

  • 06

    Sep

  • 08

    Sep

  • 15

    Sep

  • 09

    Oct

BABA

Alibaba

$171.47

2.22 (1.31%)

, VMW

VMware

$98.97

1.96 (2.02%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

BABA

Alibaba

$171.47

2.22 (1.31%)

VMW

VMware

$98.97

1.96 (2.02%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

EL

Estee Lauder

$106.53

0.05 (0.05%)

TPX

Tempur Sealy

$62.42

0.91 (1.48%)

WUBA

58.com

$63.80

-0.34 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

FEYE

FireEye

$13.77

-0.21 (-1.50%)

10:25
08/22/17
08/22
10:25
08/22/17
10:25
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

VMW

VMware

$99.09

2.08 (2.14%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:23
08/22/17
08/22
10:23
08/22/17
10:23
Hot Stocks
Deutsche ups VMware on slower than expected enterprise move to public cloud »

Deutsche Bank upgraded…

VMW

VMware

$99.09

2.08 (2.14%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

ORCL

Oracle

$49.11

0.205 (0.42%)

RHT

Red Hat

$102.19

-0.465 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

  • 05

    Sep

TWX

Time Warner

$101.80

-0.31 (-0.30%)

, T

AT&T

$37.77

0.1899 (0.51%)

10:21
08/22/17
08/22
10:21
08/22/17
10:21
Periodicals
Time Warner, AT&T deal questioned by Brazil antitrust agency, Bloomberg says »

Shares of Time Warner…

TWX

Time Warner

$101.80

-0.31 (-0.30%)

T

AT&T

$37.77

0.1899 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SHLD

Sears

$8.55

-0.1 (-1.16%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:19
08/22/17
08/22
10:19
08/22/17
10:19
Hot Stocks
Sears jumps after announcing latest licensing deals for Kenmore, DieHard brands »

Shares of Sears Holdings…

SHLD

Sears

$8.55

-0.1 (-1.16%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

LOW

Lowe's

$75.27

1.42 (1.92%)

HD

Home Depot

$150.33

1.13 (0.76%)

BBY

Best Buy

$61.37

0.9185 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 29

    Aug

  • 19

    Sep

  • 21

    Nov

$NSD

NASDAQ Market Internals

10:17
08/22/17
08/22
10:17
08/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PULM

Pulmatrix

$1.67

-0.03 (-1.76%)

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Hot Stocks
Pulmatrix patent for respirable tiotropium dry powders posted to USPTO site 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/22/17
08/22
10:15
08/22/17
10:15
General news
U.S. Richmond Fed manufacturing index was flat at 14 in August »

U.S. Richmond Fed…

AVGO

Broadcom

$249.62

0.25 (0.10%)

10:10
08/22/17
08/22
10:10
08/22/17
10:10
Options
Bullish option play in Broadcom ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.